- The Food and Drug Administration (FDA) approved a second omicron booster for people who are at least 65 or immune-compromised, an option intended to bolster protection for the most vulnerable Americans even as the pandemic The action appears likely to provide a measure of reassurance to people whose age or medical issues put them at risk of serious illness if they are infected. Some got updated boosters last fall, soon after the omicron-targeting shots were authorized, but patients and physicians recognize the mRNA vaccines have a history of waning protection within months of being administered. (Articles here, here, here, and here)
April 19, 2023
Life Sciences | Tea Leaves